|
(All-cause)
|
Log EIRa
|
3.91 (3.53–4.32)
|
3.64 (3.40–3.89)
|
4.29 (3.89–4.73)
|
–
|
–
|
–
|
–
|
|
Slide Positivity Rate (Incidence)b
|
0.89 (0.13–5.70)
|
3.10 (0.36–13.12)
|
4.29 (2.78–13.29)
|
0.48 (0.15–2.05)
|
0.73 (0.39–1.42)
|
1.70 (0.79–4.45)
|
1.55 (1.04–2.80)
|
|
Annual parasite prevalencec
|
1.23 (0.71–2.10)
|
1.04 (0.75–1.42)
|
1.11 (0.80–1.52)
|
1.15 (0.67–1.98)
|
1.23 (1.01–1.50)
|
1.04 (0.86–1.28)
|
1.10 (0.97–1.25)
|
|
Annual clinical malaria prevalencec
|
1.03 (0.44–2.32)
|
1.22 (0.68–1.84)
|
1.38 (0.87–2.19)
|
1.97 (0.88–4.17)
|
1.16 (0.86–1.58)
|
0.99 (0.72–1.36)
|
1.16 (0.97–1.40)
|
|
Five-year parasite prevalenced
|
0.64 (0.29–1.34)
|
1.32 (0.86–2.04)
|
1.50 (0.98–2.23)
|
1.38 (0.69–2.69)
|
1.23 (0.94–1.57)
|
1.04 (0.78–1.35)
|
1.15 (0.96–1.37)
|
|
Five-year clinical malaria prevalenced
|
1.05 (0.30–3.51)
|
1.65 (0.81–3.26)
|
1.89 (1.00–3.51)
|
3.94 (1.34–11.1)
|
0.99 (0.64–1.54)
|
1.07 (0.69–1.66)
|
1.32 (1.01–1.74)
|
|
(Malaria-specific)
|
Log EIRa
|
–
|
4.35 (3.72–4.95)
|
4.29 (3.61–5.06)
|
–
|
–
|
–
|
–
|
|
Slide Positivity Rate (Incidence)b
|
–
|
1.36 (0.23–9.85)
|
9.48 (5.11–37.94)
|
0.02 (0.003–0.33)
|
0.27 (0.02–3.24)
|
0.59 (0.01–13.15)
|
1.37 (0.51–3.73)
|
|
Annual parasite prevalencec
|
–
|
1.31 (0.71–2.37)
|
1.50 (0.92–2.41)
|
0.80 (0.32–2.06)
|
0.78 (0.32–1.80)
|
3.42 (1.39–8.63)
|
1.31 (0.95–1.78)
|
|
Annual clinical malaria prevalencec
|
–
|
0.94 (0.34–2.47)
|
1.58 (0.73–3.23)
|
3.65 (0.94–12.79)
|
0.36 (0.08–1.49)
|
1.67 (0.38–6.52)
|
1.34 (0.82–2.14)
|
|
Five-year parasite prevalenced
|
–
|
1.73 (0.74–4.21)
|
2.29 (1.17–4.29)
|
0.56 (0.14–2.03)
|
1.55 (0.48–4.86)
|
2.24 (0.67–7.44)
|
1.66 (1.07–2.54)
|
|
Five-year clinical malaria prevalenced
|
–
|
2.23 (0.55–8.36)
|
3.37 (1.23–8.93)
|
7.56 (1.20–39.5)
|
0.60 (0.08–3.91)
|
0.77 (0.09–5.64)
|
2.50 (1.27–4.81)
|
